CANC vs. OILK
CANC (Tema Oncology ETF) and OILK (ProShares K-1 Free Crude Oil Strategy ETF) are both exchange-traded funds - CANC is a Health & Biotech Equities fund actively managed by Tema, while OILK is a Oil & Gas fund tracking the Bloomberg Commodity Balanced WTI Crude Oil Index. CANC is actively managed, while OILK is passively managed. Over the past 3 years, CANC returned 107.71%/yr vs 18.48%/yr for OILK. At a 0.02 correlation, their price movements are largely independent. CANC charges 0.75%/yr vs 0.68%/yr for OILK.
Performance
CANC vs. OILK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CANC achieves a 4.74% return, which is significantly lower than OILK's 61.95% return.
CANC
- 1D
- -2.40%
- 1M
- -2.10%
- YTD
- 4.74%
- 6M
- 5.93%
- 1Y
- 49.25%
- 3Y*
- 107.71%
- 5Y*
- —
- 10Y*
- —
OILK
- 1D
- 1.15%
- 1M
- 0.89%
- YTD
- 61.95%
- 6M
- 59.31%
- 1Y
- 57.89%
- 3Y*
- 18.48%
- 5Y*
- 17.52%
- 10Y*
- —
CANC vs. OILK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CANC Tema Oncology ETF | 4.74% | 42.92% | -5.37% | 510.51% | -85.34% | -51.82% |
OILK ProShares K-1 Free Crude Oil Strategy ETF | 61.95% | -11.86% | 8.18% | -0.97% | 27.57% | 3.42% |
Correlation
The correlation between CANC and OILK is -0.31, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.10 |
Correlation (All Time) Calculated using the full available price history since Oct 1, 2021 | 0.02 |
The correlation between CANC and OILK shifts across timeframes, from -0.31 (1 year) to 0.02 (all time), reflecting how their relationship changes across market environments.
CANC vs. OILK - Sectors Allocation Comparison
Sectors
CANC
OILK
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
CANC
OILK
-
Basic Materials
CANC
-
OILK
-
Communication Services
CANC
-
OILK
-
Consumer Cyclical
CANC
-
OILK
Consumer Defensive
CANC
-
OILK
-
Energy
CANC
-
OILK
-
Financial Services
CANC
-
OILK
-
Industrials
CANC
-
OILK
-
Real Estate
CANC
-
OILK
-
Technology
CANC
-
OILK
-
Utilities
CANC
-
OILK
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CANC vs. OILK — Risk / Return Rank
CANC
OILK
CANC vs. OILK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tema Oncology ETF (CANC) and ProShares K-1 Free Crude Oil Strategy ETF (OILK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CANC | OILK | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.14 | 2.03 | +0.12 |
Sortino ratioReturn per unit of downside risk | 3.05 | 2.55 | +0.49 |
Omega ratioGain probability vs. loss probability | 1.35 | 1.34 | +0.01 |
Calmar ratioReturn relative to maximum drawdown | 5.75 | 3.61 | +2.14 |
Martin ratioReturn relative to average drawdown | 15.57 | 7.33 | +8.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CANC | OILK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.14 | 2.03 | +0.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.59 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.11 | -0.15 |
Drawdowns
CANC vs. OILK - Drawdown Comparison
The maximum CANC drawdown since its inception was -97.53%, which is greater than OILK's maximum drawdown of -83.76%. Use the drawdown chart below to compare losses from any high point for CANC and OILK.
Loading charts...
Drawdown Indicators
| CANC | OILK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.53% | -83.76% | -13.77% |
Max Drawdown (1Y)Largest decline over 1 year | -8.67% | -17.35% | +8.68% |
Max Drawdown (3Y)Largest decline over 3 years | -30.27% | -23.42% | -6.85% |
Max Drawdown (5Y)Largest decline over 5 years | — | -34.69% | — |
Current DrawdownCurrent decline from peak | -56.58% | -4.99% | -51.59% |
Average DrawdownAverage peak-to-trough decline | -73.20% | -32.62% | -40.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.20% | 8.56% | -5.36% |
Volatility
CANC vs. OILK - Volatility Comparison
The current volatility for Tema Oncology ETF (CANC) is 6.55%, while ProShares K-1 Free Crude Oil Strategy ETF (OILK) has a volatility of 11.11%. This indicates that CANC experiences smaller price fluctuations and is considered to be less risky than OILK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CANC | OILK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.55% | 11.11% | -4.56% |
Volatility (6M)Calculated over the trailing 6-month period | 16.79% | 23.24% | -6.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.11% | 28.86% | -5.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 280.39% | 30.11% | +250.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 280.39% | 35.98% | +244.41% |
CANC vs. OILK - Expense Ratio Comparison
CANC has a 0.75% expense ratio, which is higher than OILK's 0.68% expense ratio.
Dividends
CANC vs. OILK - Dividend Comparison
CANC's dividend yield for the trailing twelve months is around 0.05%, less than OILK's 8.29% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CANC Tema Oncology ETF | 0.05% | 0.06% | 3.00% | 0.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OILK ProShares K-1 Free Crude Oil Strategy ETF | 8.29% | 4.79% | 3.11% | 5.80% | 17.32% | 68.82% | 0.13% | 0.94% | 0.58% | 6.17% |
Frequently Asked Questions
CANC and OILK have a correlation of -0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OILK has higher volatility (11.11%) compared to CANC (6.55%). In terms of maximum drawdown, CANC dropped -97.53% vs OILK's -83.76%.
On 3-year performance, CANC leads with 107.71% vs 18.48% for OILK. On fees, OILK is cheaper at 0.68% per year. On volatility, CANC has been the lower-risk option at 6.55%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, CANC has performed better with a 107.71% return vs 18.48%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
OILK is cheaper with a 0.68% expense ratio, compared with 0.75% for CANC.
OILK has the higher dividend yield at 8.29%, compared with 0.05% for CANC.
CANC is categorized as Health & Biotech Equities, while OILK is Oil & Gas. They also come from different issuers: Tema and ProShares. Their fees differ too: 0.75% for CANC and 0.68% for OILK.
CANC currently has the higher Sharpe Ratio (2.14 vs 2.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CANC and OILK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer